Nonetheless, the patients included in their study had both astrocytomas and oligodendrogliomas, but the WHO classification criteria for the diagnosis of DAG-G referred specifically to IDH wild-type grade 2–3 astrocytomas. The gene discussed is IDH1; the disease is oligodendroglioma.